PMID- 32031873
OWN - NLM
STAT- MEDLINE
DCOM- 20210610
LR  - 20210610
IS  - 1557-8992 (Electronic)
IS  - 1044-5463 (Linking)
VI  - 30
IP  - 3
DP  - 2020 Apr
TI  - Levels of Proneness to Boredom in Children with Attention-Deficit/Hyperactivity 
      Disorder On and Off Methylphenidate Treatment.
PG  - 173-176
LID - 10.1089/cap.2019.0151 [doi]
AB  - Objective: To evaluate the relationship between attention-deficit/hyperactivity 
      disorder (ADHD) severity and propensity for boredom in children with ADHD, both 
      on and off methylphenidate (MPH). Methods: A group of children and adolescents 
      with ADHD (n = 30), aged 7-18 years, were assessed using the Parent-Reported-ADHD 
      Rating Scale-5 (PR-ADHD-RS-5) and Short Boredom Proneness Scale (SBPS), at 
      baseline, after 3 months of MPH treatment, and again after 3 weeks of MPH 
      treatment discontinuation. Results: Significant correlation was found at baseline 
      between PR-ADHD-RS-5 and SBPS scores [n = 30, r = 0.40 (95% confidence interval 
      CI = 0.048-0.67), p = 0.027]. Both ADHD and boredom levels decreased 
      significantly after 3 months of MPH treatment. Significant correlation was found 
      between the reductions in PR-ADHD-RS-5 and SBPS scores at this time [n = 30, 
      r = 0.39 (95% CI = 0.035-0.66), p = 0.045]. MPH discontinuation for 3 weeks 
      resulted in mild but statistically significant increases in ADHD and SBPS levels. 
      No significant correlation was detected between the changes in PR-ADHD-RS-5 and 
      SBPS scores after 3 weeks of MPH discontinuation. Conclusions: Three months of 
      MPH treatment resulted in parallel improvement in ADHD severity and in the level 
      of proneness to boredom (PtB), whereas discontinuation of MPH administration is 
      associated with increases in the two parameters, causing them to approach 
      pretreatment levels. Clinicians and parents should be aware of the possibility of 
      increased PtB in children with ADHD who discontinue MPH treatment. Structured 
      daily activity and continuation of MPH treatment may preserve the beneficial 
      effects of MPH on academic and leisure activities and may prevent aggravation of 
      subjective boredom sensations that could lead to risky sensation-seeking 
      behaviors and overuse of electronic devices.
FAU - Golubchik, Pavel
AU  - Golubchik P
AD  - Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, 
      Israel.
AD  - Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel 
      Aviv, Israel.
FAU - Manor, Iris
AU  - Manor I
AD  - Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, 
      Israel.
AD  - Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel 
      Aviv, Israel.
FAU - Shoval, Gal
AU  - Shoval G
AD  - Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, 
      Israel.
AD  - Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel 
      Aviv, Israel.
FAU - Weizman, Abraham
AU  - Weizman A
AD  - Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel 
      Aviv, Israel.
AD  - Research Unit, Geha Mental Health Center, Petah Tikva, Israel.
AD  - Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Tel 
      Aviv University, Petah Tikva, Israel.
LA  - eng
PT  - Journal Article
DEP - 20200207
PL  - United States
TA  - J Child Adolesc Psychopharmacol
JT  - Journal of child and adolescent psychopharmacology
JID - 9105358
RN  - 0 (Central Nervous System Stimulants)
RN  - 207ZZ9QZ49 (Methylphenidate)
SB  - IM
MH  - Adolescent
MH  - Attention Deficit Disorder with Hyperactivity/*drug therapy/psychology
MH  - *Boredom
MH  - Central Nervous System Stimulants/*administration & dosage
MH  - Child
MH  - Female
MH  - Humans
MH  - Male
MH  - Methylphenidate/*administration & dosage
MH  - Parents
MH  - Severity of Illness Index
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - attention-deficit/hyperactivity disorder
OT  - boredom proneness
OT  - children and adolescents
OT  - methylphenidate
EDAT- 2020/02/08 06:00
MHDA- 2021/06/11 06:00
CRDT- 2020/02/08 06:00
PHST- 2020/02/08 06:00 [pubmed]
PHST- 2021/06/11 06:00 [medline]
PHST- 2020/02/08 06:00 [entrez]
AID - 10.1089/cap.2019.0151 [doi]
PST - ppublish
SO  - J Child Adolesc Psychopharmacol. 2020 Apr;30(3):173-176. doi: 
      10.1089/cap.2019.0151. Epub 2020 Feb 7.